A detailed history of Andesa Financial Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Andesa Financial Management Inc. holds 3,812 shares of BMY stock, worth $224,412. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,812
Holding current value
$224,412
% of portfolio
0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $250,486 - $284,108
3,812 New
3,812 $264,000
Q3 2022

Nov 03, 2022

BUY
$0.13 - $76.84 $448 - $265,174
3,451 New
3,451 $245,000
Q3 2021

Oct 13, 2021

SELL
$59.17 - $69.31 $3.6 Million - $4.22 Million
-60,821 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $3.37 Million - $3.67 Million
54,456 Added 855.55%
60,821 $4.06 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $377,699 - $424,800
6,365 New
6,365 $402,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Andesa Financial Management Inc. Portfolio

Follow Andesa Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andesa Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andesa Financial Management Inc. with notifications on news.